Volume 3, Issue 2 pp. 174-177
Full Access

Leg ulceration due to the antiphospholipid syndrome: successful treatment with intralesional corticosteroids and failure of prolonged stanozolol therapy

Vincent Falanga

Corresponding Author

Vincent Falanga

University of Miami School of Medicine Department of Dermatology, Miami, FL, USA

University of Miami School of Medicine Department of Medicine, Miami, FL, USA

Vincent Falanga M.D., University of Miami School of Medicine, P.O. Box 016250, Miami, FL 33126, USA. Tel. (305) 547-5975; Fax (305) 547-6191.Search for more papers by this author
Harvey Brown

Harvey Brown

University of Miami School of Medicine Department of Medicine, Miami, FL, USA

Search for more papers by this author
Jeffrey Pardes

Jeffrey Pardes

University of Miami School of Medicine Department of Dermatology, Miami, FL, USA

Search for more papers by this author
Robert S. Kirsner

Robert S. Kirsner

University of Miami School of Medicine Department of Dermatology, Miami, FL, USA

Search for more papers by this author

Abstract

The clinical manifestations of the antiphospholipid antibody syndrome (APLA) include thrombosis, thrombocytopenia and recurrent fetal loss. Livedo reticularis and leg ulceration may occur as the result of vascular occlusion, and are difficult to treat. We report a patient with a painful leg ulceration and livedo reticularis secondary to APLA in whom intralesional triamcinolone injections induced rapid and complete healing of the ulceration. A year later, the ulcer has not recurred. Initial and prolonged treatment with stanozolol, an androgenic steroid with fibrinolytic properties that has been proposed as a treatment for this condition, seemed to help at first but failed to cause persistent healing. We suggest that intralesional injection of corticosteroids should be the initial treatment of choice in ulcers due to APLA.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.